Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain.
Breast neoplasm
Mammography
Mass screening
Sensitivity
Journal
Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104
Informations de publication
Date de publication:
29 Jan 2024
29 Jan 2024
Historique:
received:
25
07
2023
accepted:
10
12
2023
medline:
29
1
2024
pubmed:
29
1
2024
entrez:
29
1
2024
Statut:
aheadofprint
Résumé
To ensure high-quality screening programmes and effective utilization of resources, it is important to monitor how cancer detection is affected by different strategies performed at recall assessment. This study aimed to describe procedures performed at recall assessment and compare and evaluate the performance of the assessment in Denmark, Norway, and Spain in terms of screen-detected cancer (SDC) and interval cancer (IC) rates. We included women aged 50-69 years from Denmark, Norway, and Spain, who were recalled for assessment after screening mammography, and recorded all procedures performed during six months after diagnosis, and the timing of the procedures. Women were followed for two years and screen-detected and interval cancer, and sensitivity of recall was calculated and compared. In total, data from 24,645 Danish, 30,050 Norwegian, and 41,809 Spanish women were included in the study. Most of the women had some assessment within 2 months in all three countries. SDC rates were higher in Denmark (0.57) and Norway (0.60) compared to Spain (0.38), as were the IC rates, i.e. 0.25 and 0.18 vs. 0.12, respectively. The sensitivity of the diagnostic follow-up was somewhat higher in Denmark (98.3%) and Norway (98.2%), compared to Spain (95.4%), but when excluding non-invasive assessment pathways, the sensitivities were comparable. This comparison study showed variation in the assessment procedures used in the three countries as well as the SDC and IC rates and the sensitivity of recall.
Identifiants
pubmed: 38285110
doi: 10.1007/s10549-023-07219-0
pii: 10.1007/s10549-023-07219-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Altobelli E, Lattanzi A (2014) Breast cancer in European Union: an update of screening programmes as of March 2014 (review). Int J Oncol 45(5):1785–1792
doi: 10.3892/ijo.2014.2632
pubmed: 25174328
pmcid: 4203333
Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, et al. (2006) European guidelines for quality assurance in breast cancer screening and diagnosis. 4th edn, p 416
Olivotto IA, Gomi A, Bancej C, Brisson J, Tonita J, Kan L et al (2002) Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer 94(8):2143–2150
doi: 10.1002/cncr.10453
pubmed: 12001110
Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, et al. (2018) Timely follow-up of positive cancer screening results: a systematic review and recommendations from the PROSPR Consortium. CA: A Cancer Journal for Clinicians
Hafslund B, Nortvedt MW (2009) Mammography screening from the perspective of quality of life: a review of the literature. Scand J Caring Sci 23(3):539–548
doi: 10.1111/j.1471-6712.2008.00634.x
pubmed: 19170959
Muratov S, Canelo-Aybar C, Tarride J-E, Alonso-Coello P, Dimitrova N, Borisch B et al (2020) Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators. BMC Cancer 20(1):795
doi: 10.1186/s12885-020-07289-z
pubmed: 32831048
pmcid: 7444070
Dansk Kvalitetsdatabase for Mammografiscreening (2007) Mammografiscreening i Danmark. Kliniske Retningslinjer [Mammography screening in Denmark. Clinical guidelines]. Contract No.: Report
Mikkelsen EM, Njor SH, Vejborg I (2016) Danish quality database for mammography screening. Clin Epidemiol 8:661–666
doi: 10.2147/CLEP.S99467
pubmed: 27822113
pmcid: 5094619
Sundhedsstyrelsen (2018) Pakkeforløb for brystkræft [breast cancer care pathway] (in Danish) Copenhagen [Available from: https://www.sst.dk/da/Viden/Kraeft/Kraeftpakkeforloeb/Oversigt-over-kraeftpakkeforloeb
Styregruppen for Dansk Kvalitetsdatase for Mammografiscreening (2019) Dansk Kvalitetsdatabase for Mammografiscreening. Årsrapport 2019 [Danish quality database of mammography screening, Report 2019]: Regionernes Kliniske Kvalitetsudviklingsprogram (RKKP); [Available from: https://www.sundhed.dk/content/cms/78/4678_dkms_rapport2019_endelig.pdf
Hofvind S, Geller B, Vacek PM, Thoresen S, Skaane P (2007) Using the European guidelines to evaluate the Norwegian breast cancer screening program. Eur J Epidemiol 22(7):447–455
doi: 10.1007/s10654-007-9137-y
pubmed: 17594526
Hofvind S, Skaane P, Elmore JG, Sebuødegård S, Hoff SR, Lee CI (2014) Mammographic performance in a population-based screening program: before, during, and after the transition from screen-film to full-field digital mammography. Radiology 272(1):52–62
doi: 10.1148/radiol.14131502
pubmed: 24689858
Bjørnson EWHÅS, Sagstad S, Larsen M, Thy J, Mangerud G, Ertzaas AK, Hofvind S (2022) Breast Screen Norway: 25 years of organized screening. Cancer Registry of Norway, Oslo
Ascunce N, Salas D, Zubizarreta R, Almazán R, Ibáñez J, Ederra M (2010) Cancer screening in Spain. Ann Oncol 21(Suppl 3):43–51
doi: 10.1093/annonc/mdq085
Sickles EDO CB, LW et al. (2013) ACR BI-RADS
Red de Programas de Cribado de Cáncer. Programas de Cribado de Cáncer de Mama. Informe de evaluación 2017. Available from: www.cribadocancer.es
Gjerstorff ML (2011) The Danish cancer registry. Scand J Public Health 39(7):42–45
doi: 10.1177/1403494810393562
pubmed: 21775350
Bjerregaard B, Larsen OB (2011) The Danish Pathology Register. Scand J Public Health. 39(7_suppl):72–74
doi: 10.1177/1403494810393563
pubmed: 21775357
Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT (2015) The Danish national patient registry: a review of content, data quality, and research potential (Report). Clin Epidemiol 7:449
doi: 10.2147/CLEP.S91125
pubmed: 26604824
pmcid: 4655913
Schmidt M, Pedersen L, Sørensen HT (2014) The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol 29(8):541–549
doi: 10.1007/s10654-014-9930-3
pubmed: 24965263
Román M, Louro J, Posso M, Vidal C, Bargalló X, Vázquez I et al (2022) Long-Term Risk of Breast Cancer after Diagnosis of Benign Breast Disease by Screening Mammography. Int J Environ Res Public Health 19(5):2625
doi: 10.3390/ijerph19052625
pubmed: 35270331
pmcid: 8909630
Louro J, Román M, Posso M, Comerma L, Vidal C, Saladié F et al (2020) Differences in breast cancer risk after benign breast disease by type of screening diagnosis. Breast 54:343–348
doi: 10.1016/j.breast.2020.09.005
pubmed: 33023825
pmcid: 7770442
Quan ML, Shumak RS, Majpruz V, Holloway CMD, O’Malley FP, Chiarelli AM (2012) Improving work-up of the abnormal mammogram through organized assessment: results from the Ontario breast screening program. J Oncol Pract 8(2):107–112
doi: 10.1200/JOP.2011.000413
pubmed: 23077438
pmcid: 3457814
Screening & Immunisations Team (NHS Digital) & PHE Screening PHE (2020) Breast screening programme England, 2018–19 [homepage on the internet]. [Available from: https://digital.nhs.uk/data-and-information/publications/statistical/breast-screening-programme/england---2018-19
Netherlands Comprehensive Cancer Organization (2018) National evaluation of breast cancer screening in the Netherlands June 2018 [homepage on the internet]. [updated May 2018. Available from: https://www.iknl.nl/en/screening
Helsedirektoratet (2014) Brystkreft [updated 29/04/2021. Available from: https://www.helsedirektoratet.no/nasjonale-forlop/brystkreft
Ganry O, Peng J, Dubreuil A (2004) Influence of abnormal screens on delays and prognostic indicators of screen-detected breast carcinoma. J Med Screen 11(1):28–31
doi: 10.1177/096914130301100107
pubmed: 15006111
Danckert BFJ, Engholm G , Hansen HL, Johannesen TB, Khan S, Køtlum JE, Ólafsdóttir E, Schmidt LKH, Virtanen A and Storm HH (2019) NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic Countries, Version 8.2 (26.03.2019) [homepage on the internet]. Association of the Nordic Cancer Registries. Danish Cancer Society. Available from: http://www.ancr.nu
Ferlay J EM, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020) Global cancer observatory: cancer today [homepage on the internet]. International Agency for Research on Cancer, Lyon, France [Available from: https://gco.iarc.fr/today
Ciatto S, Houssami N, Ambrogetti D, Bonardi R, Collini G, Del Turco MR (2007) Minority report—false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis. Breast Cancer Res Treat 105(1):37–43
doi: 10.1007/s10549-006-9425-3
pubmed: 17115112
von Euler-Chelpin M, Kuchiki M, Vejborg I (2014) Increased risk of breast cancer in women with false-positive test: the role of misclassification. Cancer Epidemiol 38(5):619–622
doi: 10.1016/j.canep.2014.06.006